India Patent Cases
2,847 decisions indexed
Page 17 of 95 · 2,847 total
University College London v.The Assistant Controller of Patents and Designs
University College London appealed an order rejecting its divisional patent application concerning 'A Delayed Release Drug Formulation.' The core dispute centered on whether the complete specification of the parent application related to more than one invention, which was the basis for rejection. The appellant argued that their claims were distinct and did not constitute double patenting. The Madras High Court set aside the impugned order and remanded the matter back to the Controller for reconsideration.
Jansen Pharmaceutica Nv v.Deputy Controller Of Patents And Designs
Jansen Pharmaceutica appealed the rejection of its patent application for a dry, intravenously administrable formulation of tipifarnib. The Controller rejected the application, citing lack of inventive steps and non-patentability under Section 3(e). The High Court found that the impugned order was vague, lacked reasoning, and failed to apply established principles for determining inventive steps.
Dr. Joy Vadakkan Thomas v.The Assistant Controller of Patents and Designs
Dr. Joy Vadakkan Thomas appealed an order rejecting Patent Application No. 201941042481 for a method to capture carbon dioxide. The rejection was based on lack of inventive step and non-patentability under Section 3(d). The High Court set aside the impugned order, noting that new grounds were raised by the respondent, and remanded the matter for reconsideration.
Emerson Process Management Power & Water Solutions, Inc. v.Assistant Controller of Patents and Designs
The petitioner appealed against an order rejecting its patent application (No. 2416/CHE/2009) for 'TWO-STAGE MODEL PREDICTIVE CONTROL TECHNIQUE'. The rejection was based on Section 3(k), classifying the claims as a mere computer programme per se. The High Court set aside the impugned order, finding that the patent office failed to discuss or record reasons for rejecting the appellant's contentions.
Cellectis v.The Assistant Controller Of Patents And Designs
Cellectis appealed a refusal order by the Controller of Patents regarding its patent application for a method involving T-Cells. The appeal sought permission to file amended claims and complete specification. The court examined whether these amendments were permissible under Section 59 of the Patents Act.
Navya Network Inc. v.The Controller of Patents & Designs
Navya Network Inc. appealed the rejection of its patent application for 'TREATMENT RELATED QUANTITATIVE DECISION ENGINE'. The Controller raised objections regarding lack of novelty, lack of inventive step, and exclusion under Section 3(k). The High Court dismissed the appeal, finding that the invention was obvious to a Person Skilled in the Art (PSITA) based on cited prior art.
Magneti Marelli S.P.A. v.The Assistant Controller of Patents & Designs
Magneti Marelli appealed a decision by the Assistant Controller of Patents & Designs rejecting its patent application (No. 420/CHE/2009) on grounds of lack of inventive step based on prior art citations. The appellant argued that the rejection order failed to discuss their submissions distinguishing the invention from the cited prior arts. The High Court found that the respondent's order was unsupported by reasons and set it aside, remanding the matter for reconsideration.
Tvs Motor Company Limited v.The Controller of Patents & Designs
TVS Motor Company appealed a rejection order issued by The Controller of Patents & Designs regarding its patent application for a Vehicle Monitoring System. The appellant argued that certain prior art documents did not qualify as prior art or failed to disclose the claimed invention's features, particularly data transmission capabilities when the vehicle is switched off. The High Court set aside the impugned order and remanded the matter for fresh consideration.
Daikin Industries Ltd v.Union If India And Ors
Daikin Industries Ltd appealed against an order rejecting its patent application for "AIR CONDITIONING APPARATUS" due to a lack of inventive step. The court found that the rejection order was unreasoned, cryptic, and failed to apply independent mind to the prior art documents cited. Consequently, the matter was remanded back to the Controller for fresh hearing.
Vennootschap v.The Controller General Of Patents And Designs And Anr
The petitioner appealed against an order rejecting its patent application, which was based on a lack of inventive steps. The petitioner argued that the rejection was mechanically passed and violated natural justice because new prior art (D-2) was introduced at the hearing stage without being mentioned in the initial examination report. The Court agreed, finding no reasons in the impugned order.
Andreas Gutzeit v.The Controller General of Patents Designs and Trademark and Anr.
This matter before the Calcutta High Court's Intellectual Property Rights Division involves Andreas Gutzeit challenging a patent-related issue against The Controller General of Patents. The appellant raised a pure question of law concerning the interpretation of Section 59 of the Patents Act, 1970. Given the complexity and legal nature of the dispute, the court granted a final adjournment to allow both parties time to file their Written Notes of Submissions.
Upl Limited v.Union Of India & Ors.
Upl Limited challenged a communication from respondent authorities that cancelled a scheduled hearing for its patent application, citing redundancy in cited prior art. The petitioner argued this cancellation was unjustifiable without following procedural mandates. The court found serious infractions of procedure and directed the matter to be reassigned and heard afresh.
Smart Call Centre Solution Private Limited v.Harinder Singh And Anr.
The plaintiff filed a suit seeking damages against the defendant for alleged disclosure of confidential and proprietary information. The court granted leave under Clause 12 of Letters Patent and dispensed with the pre-mediation process due to grave urgency. Subsequently, an interim order was passed restraining the defendant from disclosing or utilizing confidential client data and trade secrets.
The Regents Of The University Of California v.The Controller Of Patents
The Regents of the University of California appealed the refusal of their patent application concerning a recombinant Salmonella microorganism based live vaccine. The Controller argued that the broad scope of the claims led to two major issues: first, they potentially covered naturally occurring loss-of-function variants, making them non-patentable under Section 3(c) of the Patents Act; and second, the complete specification lacked sufficient disclosure and clarity for the wide range of organisms claimed. The Delhi High Court upheld the Controller's decision, dismissing the appeal on grounds of insufficient disclosure and non-patentability.
Hero Investcorp Private Limited & Anr v.M.M. Oil Traders
The Delhi High Court granted several interim reliefs in favor of Hero Investcorp Private Limited, which is suing M.M. Oil Traders for infringement. The court allowed the plaintiffs to file additional documents and exempted them from advance service and pre-institution mediation due to the urgent nature of the case. Crucially, the court appointed a Local Commissioner with broad powers to confiscate infringing products and inspect the defendant's accounts, signaling strong judicial support for the plaintiff's claims regarding trademark, design, and copyright infringement.
UPL Limited v.Astec Lifeciences Limited And Anr
The appeal challenged an earlier pre-grant objection order passed under Section 25 of the Patents Act, 1970. The court found that the impugned order suffered from a gross violation of natural justice due to its mechanical and verbatim reproduction of the private respondent's submissions without independent application of mind. Consequently, the court set aside the order and remanded the matter.
Koninklijke Philips Electronics N.V. v.Maj(Retd) Sukesh Behl & Anr
Koninklijke Philips Electronics N.V. initiated legal proceedings against Maj(Retd) Sukesh Behl and others concerning a Suit Patent related to an 8/16 modulation method used in data recording on discs. The court addressed complex issues, including the patent's validity under various sections of the Patents Act (such as novelty, sufficiency of disclosure, and non-patentability). Ultimately, after analyzing infringement claims and the defendants' conduct, the judgment focused on determining appropriate FRAND royalty rates for the patented technology.
Evonik Operations Gmbh And Anr v.The Controller Of Patents And Designs And Anr.
This appeal was filed by Evonik Operations Gmbh challenging an order dated May 2, 2023, which rejected Patent Application No. 201837000665. The court directed the appellants to file an Informal Paper Book and listed the matter for April 2025.
F Hoffmann-La Roche Ltd & Others v.Drugs Controller General of India & Others
The plaintiffs, innovators of biological drugs 'bevacizumab' (AVASTIN) and 'trastuzumab' (HERCEPTIN), filed suits against generic manufacturers (Hetero and Cadila) seeking permanent injunctions. The current judgment addresses applications for the disclosure and production of documents related to the defendants' regulatory approvals, arguing that the approvals were obtained by suppressing material facts.
Tahoe Research Ltd. v.The Controller of Patents
Tahoe Research Ltd appealed the rejection of its patent application (No. 201647014734) by The Controller of Patents. The appellant argued that principles of natural justice were violated regarding lack of clarity objections, and that the novelty analysis incorrectly applied EPO reasoning without considering material differences in the claims.
F Hoffmann-La Roche Ltd v.Drugs Controller General Of India
The plaintiffs, innovators of biological cancer drugs 'bevacizumab' (AVASTIN) and 'trastuzumab' (HERCEPTIN), filed suits against the Drugs Controller General of India and associated defendants. The current judgment addresses applications seeking disclosure and production of documents related to the DCGI approvals granted to bio-similar versions of these drugs.
Vgx Pharmaceuticals Inc v.The Controller General Of Patents, Designs And Trademarks
Vgx Pharmaceuticals Inc challenged the refusal of its patent application concerning 'Electroporation Devices and Methods.' The appeal argued that the Assistant Controller's order was unreasoned, failing to provide a clear justification for rejecting the invention based on prior art D4 and D5. The Delhi High Court agreed, finding the impugned order cryptic and lacking necessary analysis regarding inventive step. Consequently, the court allowed the appeal, setting aside the refusal and remanding the matter back to the Patent Office for fresh consideration.
Parle Elizabeth Tools Private Limited v.Pacific Tools Private Limited
The petitioners filed a petition seeking the revocation of patent number 420765, which was granted in favour of respondent no.1. The court allowed an application for exemption from filing copies and listed the main petition for further proceedings.
Mr Abhishek Sharma & Anr. v.Assistant Controller Of Patents And Designs
The appellants appealed a decision by the Assistant Controller of Patents and Designs refusing their patent application (No. 202111053480). The subject matter related to 'black coloured wearing' and its alleged effects on human health, which the Controller rejected as non-technical and an abstract theory lacking scientific evidence. The High Court dismissed the appeal both on merits and due to the inordinate delay in filing.
Shimadzu Corporation v.The Assistant Controller of Patents and Designs, The Patent Office
Shimadzu Corporation appealed an order rejecting its patent application (No. 201647043103), which concerned a surrogate biomarker for evaluating amyloid beta peptide accumulation. The rejection was based on Section 3(i) of the Patents Act, 1970, as it related to diagnostic methods. The High Court set aside the order and remanded the matter, finding that the appellants were prejudiced by not having access to a key judgment before the initial hearing.
The Trustees Of Columbia University v.The Assistant Controller of Patents and Designs
The appellant challenged an order rejecting its amended patent claims (1-19) for 'METHODS AND COMPOSITIONS FOR TREATMENT OF AMYLOID DEPOSITION DISEASES' under Section 59 of the Patents Act. The appellant argued that the amendments were supported by the complete specification, citing relevant case law. The High Court set aside the impugned order and remanded the matter for fresh reconsideration.
Hamrish Kumar Rajakumar v.Indian Council of Medical Research (ICMR)
The appellant filed an RTI seeking comprehensive information from ICMR regarding the legal framework, ownership, and formalities associated with protecting a Clinical Outcome Assessment (COA) tool developed by undergraduate students. The Commission found that the PIO had disclosed available public domain information, but directed ICMR to provide the Appellant with its detailed Intellectual Property Policy for complete transparency.
Sebille Educations Pvt. Ltd. v.Nikita Dubey Rai
Sebille Educations Pvt. Ltd. filed a suit against Nikita Dubey Rai, alleging infringement of its registered trademark 'LITTLE EINSTEINS' and associated copyrights in the field of educational services. The plaintiffs sought permanent injunctions against the use of deceptively similar marks like 'LEARNING EINSTEINS'. However, both parties amicably settled their dispute through a joint memorandum of compromise dated February 6, 2025.
Jupeng Bio (Hk) Limited v.The Controller of Patents and Designs, Government of India
Jupeng Bio appealed an order rejecting its patent application for 'Control of Conductivity in Anaerobic Fermentation'. The appellant challenged the rejection, arguing that the prior art cited did not explicitly disclose all claimed elements (conductivity and SCU relationship), and that the reasons for rejection under Section 3(d) were unreasoned. The High Court found deficiencies in the respondent's reasoning regarding both novelty and Section 3(d) non-patentability.
Novartis Ag v.Cdymax (India) Pharma Private Limited
The plaintiffs seek a permanent injunction against the defendant for infringing their patent related to the compound Ribociclib, used in breast cancer treatment. The defendant allegedly started manufacturing and exporting the patented compound without authorization.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.